Wenger Vieli advised Xeltis on the deal. Xeltis is a pioneering medtech firm developing medical devices enabling cardiovascular restoration. The Swiss/Dutch university spin-off landed a €15…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
